70 related articles for article (PubMed ID: 31301662)
1. Fluidity of Poly (ε-Caprolactone)-Based Material Induces Epithelial-to-Mesenchymal Transition.
Mano SS; Uto K; Ebara M
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143443
[TBL] [Abstract][Full Text] [Related]
2. CLIC4 Function in the Epithelial-Mesenchymal Transition of Epithelial Odontogenic Lesions.
Xerez MC; da Silva Barros CC; de Souto Medeiros MR; Mafra RP; de Lucena HF; da Silveira ÉJD; de Lisboa Lopes Costa A
Head Neck Pathol; 2024 May; 18(1):40. PubMed ID: 38727794
[TBL] [Abstract][Full Text] [Related]
3. Vulvo-vaginal epithelial tumors in mares: A preliminary investigation on epithelial-mesenchymal transition and tumor-immune microenvironment.
Armando F; Porcellato I; de Paolis L; Mecocci S; Passeri B; Ciurkiewicz M; Mechelli L; Grazia De Ciucis C; Pezzolato M; Fruscione F; Brachelente C; Montemurro V; Cappelli K; Puff C; Baumgärtner W; Ghelardi A; Razzuoli E
Vet Pathol; 2024 May; 61(3):366-381. PubMed ID: 37909398
[TBL] [Abstract][Full Text] [Related]
4. Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis.
Beer L; Sahin H; Bateman NW; Blazic I; Vargas HA; Veeraraghavan H; Kirby J; Fevrier-Sullivan B; Freymann JB; Jaffe CC; Brenton J; Miccó M; Nougaret S; Darcy KM; Maxwell GL; Conrads TP; Huang E; Sala E
Eur Radiol; 2020 Aug; 30(8):4306-4316. PubMed ID: 32253542
[TBL] [Abstract][Full Text] [Related]
5. Pituitary tumor transforming gene PTTG2 induces psoriasis by regulating vimentin and E-cadherin expression.
Liu XB; Li F; Li YQ; Yang F
Int J Clin Exp Pathol; 2015; 8(9):10887-93. PubMed ID: 26617803
[TBL] [Abstract][Full Text] [Related]
6. Ciliated Cells in Ovarian Cancer Decrease with Increasing Tumor Grade and Disease Progression.
Richardson MT; Recouvreux MS; Karlan BY; Walts AE; Orsulic S
Cells; 2022 Dec; 11(24):. PubMed ID: 36552773
[TBL] [Abstract][Full Text] [Related]
7. Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis.
Sethi S; Macoska J; Chen W; Sarkar FH
Am J Transl Res; 2010 Oct; 3(1):90-9. PubMed ID: 21139809
[TBL] [Abstract][Full Text] [Related]
8. Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer.
Xu T; Verhagen MP; Teeuwssen M; Sun W; Joosten R; Sacchetti A; Ewing-Graham PC; Jansen MPHM; Boere IA; Bryce NS; Zeng J; Treutlein HR; Hook J; Hardeman EC; Gunning PW; Fodde R
Cell Death Differ; 2024 Mar; 31(3):360-377. PubMed ID: 38365970
[TBL] [Abstract][Full Text] [Related]
9. Association between the expression of epithelial-mesenchymal transition (EMT)-related markers and oncologic outcomes of colorectal cancer.
Emile MH; Emile SH; El-Karef AA; Ebrahim MA; Mohammed IE; Ibrahim DA
Updates Surg; 2024 May; ():. PubMed ID: 38762631
[TBL] [Abstract][Full Text] [Related]
10. N-cadherin-mediated adhesion and signaling from development to disease: lessons from mice.
Radice GL
Prog Mol Biol Transl Sci; 2013; 116():263-89. PubMed ID: 23481199
[TBL] [Abstract][Full Text] [Related]
11. Impact of Epithelial-Mesenchymal Transition on the Immune Landscape in Breast Cancer.
Khadri FZ; Issac MSM; Gaboury LA
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680248
[TBL] [Abstract][Full Text] [Related]
12. The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features.
Romani C; Capoferri D; Grillo E; Silvestri M; Corsini M; Zanotti L; Todeschini P; Ravaggi A; Bignotti E; Odicino F; Sartori E; Calza S; Mitola S
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671478
[TBL] [Abstract][Full Text] [Related]
13. Reversal of Epithelial-Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids.
Lee CH
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766574
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition in serous and mucinous epithelial tumors of the ovary.
Bhuyan G; Arora R; Ahluwalia C; Sharma P
J Cancer Res Ther; 2019; 15(6):1309-1315. PubMed ID: 31898665
[TBL] [Abstract][Full Text] [Related]
15. Targeting RPL23 restores chemosensitivity of cisplatin-resistant ovarian carcinoma by inhibiting EMT.
Liu Y; Lai S; He J; Wan J; Fu F; Jinlong Y
Cytotechnology; 2022 Jun; 74(3):421-432. PubMed ID: 35733701
[TBL] [Abstract][Full Text] [Related]
16. Plant-Derived Chinese Medicine Monomers on Ovarian Cancer via the Wnt/
Xu JY; Liu FY; Liu SX; Xie LZ; Li J; Ma YT; Han FJ
J Oncol; 2021; 2021():6852867. PubMed ID: 34912456
[TBL] [Abstract][Full Text] [Related]
17. A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways.
Wang B; Li H; Zhao X; Zhang W; Zhao G; Wu Z; Zhang R; Dong P; Watari H; Tigyi G; Li W; Yue J
J Cancer; 2021; 12(18):5654-5663. PubMed ID: 34405025
[TBL] [Abstract][Full Text] [Related]
18. EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway.
Zhao G; Zhang W; Dong P; Watari H; Guo Y; Pfeffer LM; Tigyi G; Yue J
Cell Biosci; 2021 Apr; 11(1):70. PubMed ID: 33827661
[TBL] [Abstract][Full Text] [Related]
19. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
Bozhkova DM; Poryazova-Markova EG
Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
